Home > Insider Trading > Filing (0001315406-15-000010)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
12208	Bio Rad Laboratories Inc	BIO, BIOB	Laboratory Analytical Instruments (3826)	941381833

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1248076	N Alice Schwartz	C/O Bio-Rad Laboratories, Inc. 1000 Alfred Nobel Drive Hercules CA 94547		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Bio-Rad A Common Stock	Disposition	2015-03-11	37,680	$133.95	1,835,971	No	4	S	Indirect	By Alice N. Schwartz Revocable Trust
Bio-Rad A Common Stock	Disposition	2015-03-11	22,320	$134.17	1,813,651	No	4	S	Indirect	By Alice N. Schwartz Revocable Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Alice N. Schwartz Revocable Trust
No	4	S	Indirect	By Alice N. Schwartz Revocable Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Bio-Rad A Common Stock	90	Indirect	By David Schwartz Exemption Trust
Bio-Rad A Common Stock	240	Indirect	By David Schwartz Exempt Marital Trust
Bio-Rad A Common Stock	898,931	Indirect	By David Schwartz Non-Exempt Marital Trust
Bio-Rad A Common Stock	34,311	Indirect	By Charitable Remainder Unitrust
Bio-Rad B Common Stock	440,630	Indirect	By Alice N. Schwartz Revocable Trust
Bio-Rad B Common Stock	57,000	Indirect	By David Schwartz Non-Exempt Marital Trust
Bio-Rad B Common Stock	4,060,054	Indirect	By Blue Raven Partners, L.P.
Bio-Rad B Common Stock	41,176	Indirect	By DANSA Partners Limited

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $133.05 to $134.00, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.01 to $134.54, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securites and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The shares are held by a limited partnership of which the reporting person is a limited and general partner.
The shares are held by a limited partnership of which the reporting person is a general partner.